Lucid Diagnostics Inc. Share Price

NASDAQ: LUCD

Small Cap

$1.07

as on September 18, 2025 at 1:29 am IST

$₹

Lucid Diagnostics Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.06
Day's Price Range
$1.1
$1.07
0.93%
Downside
2.80%
Upside
52 Week's Low
52 Week's High
$0.73
52-Week Price Range
$1.8
$1.07
31.78%
Downside
68.22%
Upside

Lucid Diagnostics Inc. share price movements today

Previous Close: $1.07
Open: $1.08
Volume: 1.7M
Day's Low - High: $1.06 - $1.1
52 Week Low - High: $0.73 - $1.8

Lucid Diagnostics Inc. Historical Returns

1 Month Return: + 4.9 %
3 Month Return: -13.01 %
1 Year Return: + 25.13 %
3 Year Return: -42.16 %
5 Year Return: 0 %

Lucid Diagnostics Inc. Stock Fundamentals & Key Indicators

Check Lucid Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$138.5M

EPS (TTM)

-0.455

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.92

Industry PE ratio

-3.9281873111782475

P/B Ratio

PEG Ratio

EBITDA

-47.1M

Revenue (TTM)

4.4M

Profit Margin

0.00%

Return On Equity TTM

749225700.00%

Lucid Diagnostics Inc. Stock Valuation

Track how Lucid Diagnostics Inc. P/E has moved over time to understand its valuation trends.

Lucid Diagnostics Inc. in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-0.92x)

September 17, 2025

Highest (-0.69x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.92x

Lucid Diagnostics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lucid Diagnostics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lucid Diagnostics Inc.	BUY	$138.5M	NA	-0.92	0.00%
Boston Scientific Corp.	BUY	$146.7B	149.51%	58.92	13.55%
Stryker Corporation	BUY	$144.0B	78.01%	50.02	12.25%
Abbott Laboratories	BUY	$231.1B	24.47%	16.66	32.43%
Medtronic Plc	BUY	$120.8B	-12.63%	26.02	13.63%

See all

Stock Returns calculator for Lucid Diagnostics Inc. Stock including INR - Dollar returns

The Lucid Diagnostics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lucid Diagnostics Inc. investment value today

Current value as on today

₹1,29,017

Returns

₹29,017

(+29.02%)

Returns from Lucid Diagnostics Inc. Stock

₹24,419 (+24.42%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Lucid Diagnostics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lucid Diagnostics Inc.. Average target price of $3.71

Lucid Diagnostics Inc. Share Price Target

Get share price movements and forecasts by analysts on Lucid Diagnostics Inc..

What analysts predicted

71.16%UPSIDE

Target Price

$3.71

Current Price

$1.07

Analyzed by

12 Analysts

Target

$3.71

Lucid Diagnostics Inc. target price $3.71, a slight upside of 71.16% compared to current price of $1.07. According to 12 analysts rating.

Lucid Diagnostics Inc. Stock's Interest Amongst Investors

Search interest for Lucid Diagnostics Inc. Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:27% versus previous 30 day period

Lucid Diagnostics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	1	1	0	1	1	0	1
Gross Profit	0	-1	0	0	0	0	0	0	0	0
Operating Income	-14	-11	-11	-11	-10	-11	-11	-12	-12	-11
EBITDA	-15	-10	-13	-10	-10	-10	-12	-11	-26	-4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-11	-14	-10	-10	-11	-12	-11	-26	-4
Income Tax Expense	1,963	0	-2	-1,960	7,496	-	-12,358	7,496	9,110	3,449
Net Income	-1,979	-11	-14	-10	-10	-11	-12	-11	-26	-4
Net Profit Margin	-443777.35%	-7157.86%	-1814.56%	-1041.35%	-1060.14%	-1127.56%	-1055.55%	-964.16%	-3249.76%	-381.69%

Lucid Diagnostics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	0	0	2	4
Gross Profit	-	-	0	-3	-6	-3
Operating Income	-4	-8	-27	-56	-48	-46
EBITDA	-4	-8	-27	-54	-49	-44
Interest Expense	-	-	0	0	0	0
Depreciation	-	-	0	1	2	1
Income Before Tax	-4	-8	-28	-56	-52	-45
Income Tax Expense	-4	-8	0	1	2	7,496
Net Income	-4	-8	-28	-56	-52	-45
Net Profit Margin	0.00%	0.00%	-5615.60%	-14899.47%	-2169.11%	-1047.61%

Lucid Diagnostics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	-14	-10	-10	-11	-12	-11	-26	-4,439
Operating Cash Flow	-7	-8	-9	-12	-11	-10	-9	-12	-10,549
Investing Cash Flow	0	0	0	0	-	0	0	-93	-25
Financing Cash Flow	0	0	5	18	11	0	17	15	16,459
Change in Cash	-6	-8	-5	5	0	-10	7	2,880	5,885

Lucid Diagnostics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-8	-28	-56	-52	-45
Operating Cash Flow	-2	-5	-17	-29	-32	-44
Investing Cash Flow	0	0	0	-4	0	0
Financing Cash Flow	2	5	72	2	29	48
Change in Cash	0	0	53	-31	-3	3

Global Institutional Holdings in Lucid Diagnostics Inc.

Funds	Holdings
Masters Capital Management LLC	2.52%
Alyeska Investment Group, L.P.	1.74%
Vanguard Group Inc	0.82%
Renaissance Technologies Corp	0.42%
Luminus Management, LLC	0.42%

See all

Insights on Lucid Diagnostics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -26.90M → -4.43M (in $), with an average increase of 506.2% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, LUCD has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 828.0K → 1.16M (in $), with an average increase of 28.8% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 137.4% return, outperforming this stock by 179.6%
NEGATIVE IMPACT
Price Dip
In the last 3 months, LUCD stock has moved down by -15.1%

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. It is also developing EsoCure, is an Esophageal Ablation Device, which is a technology that allows a clinician to treat dysplastic BE.

Organisation	Lucid Diagnostics Inc.
Headquarters	360 Madison Avenue, New York, NY, United States, 10017
Industry	Healthcare
CEO	Dr. Lishan Aklog M.D.
E-voting on shares	Click here to vote

Key Management of Lucid Diagnostics Inc.

Name	Title
Dr. Lishan Aklog M.D.	Chairman & CEO
Mr. Michael Adam Gordon	General Counsel & Secretary
Helen Moinova Ph.D.	Co-Founder & Strategic Advisor
Dr. Brian J. deGuzman M.D.	Chief Technology & Compliance Officer
Dr. Suman M. Verma M.D., Ph.D.	Chief Scientific Officer
Mr. Shaun M. O'Neill M.B.A.	President & COO
Mr. Dennis M. McGrath CPA	Chief Financial Officer
Dr. Sanford D. Markowitz M.D., Ph.D.	Co-Founder & Strategic Advisor
Dr. Joseph Willis M.D.	Co-founder & Strategic Advisor
Dr. Amitabh Chak M.D.	Co-Founder & Strategic Advisor

FAQs

What is Lucid Diagnostics Inc. share price today?

Lucid Diagnostics Inc. share price today is $1.07 as on September 18, 2025 at 1:29 am IST at the close of the market. Lucid Diagnostics Inc. share today touched a day high of $1.1 and a low of $1.06.

What is the 52 week high and 52 week low for Lucid Diagnostics Inc. share?

Lucid Diagnostics Inc. share touched a 52 week high of $1.8 on April 8, 2025 and a 52 week low of $0.73 on September 23, 2024. Lucid Diagnostics Inc. stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.07,which is 40.56% down from its 52 week high and 46.58% up from its 52 week low.

What is Lucid Diagnostics Inc.'s market capitalisation today?

Lucid Diagnostics Inc. market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Lucid Diagnostics Inc. Stock (LUCD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lucid Diagnostics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lucid Diagnostics Inc. Shares that will get you 1.4019 shares as per Lucid Diagnostics Inc. share price of $1.07 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lucid Diagnostics Inc. Stock (LUCD) from India?

Indian investors can start investing in Lucid Diagnostics Inc. (LUCD) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 6:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Lucid Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 6:39 am IST). Based on Lucid Diagnostics Inc. share’s latest price of $1.07 as on September 18, 2025 at 1:29 am IST, you will get 9.3458 shares of Lucid Diagnostics Inc.. Learn more about fractional shares .